| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2005-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ada89e458bd257170fac9914639e8a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e7921c3d0f5c34ead50df2516bd8a7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace4c83e6ff48a1347f1fe07df9280a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf47a9f87615311a632584d4c5320b46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_137bc7490003e9d6a3727d54d9cfc75b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f177766e39d19625902d28e999e47cc8 |
| publicationDate |
2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7655240-B2 |
| titleOfInvention |
Vaccine composition comprising an immunoadjuvant compound consisting of a Rho GTPase family activator |
| abstract |
This invention is based on the experimental finding that activators of Rho GTPases, namely the cytotoxic necrotizing factor 1 (CNF1), and DNT bear immunostimulatory properties towards the systemic response to orally administered ovalbumine. This invention concerns a vaccine composition including an immunoadjuvant compound, wherein the immunoadjuvant compound consists of a Rho GTPase activator. |
| priorityDate |
2004-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |